Top

Current Treatment Options in Cardiovascular Medicine

Published in:

01-10-2019 | Aortic Valve Replacement | Imaging (Q Truong, Section Editor)

Clinical Applications of Echo Strain Imaging: a Current Appraisal

Authors: Agostina M. Fava, MD, Dane Meredith, MD, Milind Y. Desai, MD

Published in: Current Treatment Options in Cardiovascular Medicine | Issue 10/2019

Abstract

Purpose of review

This article reviews recent advances in echocardiographic strain imaging, particularly in its ability to prognosticate in cardiovascular outcomes and impact clinical decision making.

Recent findings

Strain has been proposed as a sensitive tool in detecting early ventricular dysfunction. Left ventricular global longitudinal strain (LV-GLS) detects subtle changes in myocardial function, often not quantifiable by ejection fraction alone. Thus, LV-GLS provides the opportunity for early decision-making, and the implementation of more effective treatments, improving outcomes in a variety of diseases such as valvular heart diseases, cardio-oncology, ischemic heart disease, cardiomyopathies, heart transplantation, and pericardial diseases and cardiomyopathies.

Summary

Strain is a promising tool for the early detection of myocardial dysfunction in patients with preserved left ventricular ejection fraction and can prognosticate long-term outcomes.

Geyer H, Caracciolo G, Abe H, Wilansky S, Carerj S, Gentile F, et al. Assessment of myocardial mechanics using speckle tracking echocardiography: fundamentals and clinical applications. J Am Soc Echocardiogr. 2010;23(4):351–69. https://doi.org/10.1016/j.echo.2010.02.015.CrossRefPubMed

Yingchoncharoen T, Agarwal S, Popović ZB, Marwick TH. Normal ranges of left ventricular strain: a meta-analysis. J Am Soc Echocardiogr. 2013;26(2):185–91. https://doi.org/10.1016/j.echo.2012.10.008.CrossRefPubMed

Felker GM, Thompson RE, Hare JM, Hruban RH, Clemetson DE, Howard DL, et al. Underlying causes and long-term survival in patients with initially unexplained cardiomyopathy. N Engl J Med. 2000;342(15):1077–84. https://doi.org/10.1056/nejm200004133421502.CrossRefPubMed

Thavendiranathan P, Poulin F, Lim K-D, Plana JC, Woo A, Marwick TH. Use of myocardial strain imaging by echocardiography for the early detection of cardiotoxicity in patients during and after cancer chemotherapy: a systematic review. J Am Coll Cardiol. 2014;63(25, Part A):2751–68. https://doi.org/10.1016/j.jacc.2014.01.073.CrossRefPubMed

Kwon DH, Setser RM, Thamilarasan M, Popovic ZV, Smedira NG, Schoenhagen P, et al. Abnormal papillary muscle morphology is independently associated with increased left ventricular outflow tract obstruction in hypertrophic cardiomyopathy. Heart. 2008;94(10):1295–301.CrossRef

Negishi K, Negishi T, Hare JL, Haluska BA, Plana JC, Marwick TH. Independent and incremental value of deformation indices for prediction of trastuzumab-induced cardiotoxicity. J Am Soc Echocardiogr. 2013;26(5):493–8. https://doi.org/10.1016/j.echo.2013.02.008.CrossRefPubMed

Mousavi N, Tan TC, Ali M, Halpern EF, Wang L, Scherrer-Crosbie M. Echocardiographic parameters of left ventricular size and function as predictors of symptomatic heart failure in patients with a left ventricular ejection fraction of 50–59% treated with anthracyclines. Eur Heart J Cardiovasc Imaging. 2015;16(9):977–84. https://doi.org/10.1093/ehjci/jev113.CrossRefPubMed

•• Ali MT, Yucel E, Bouras S, Wang L, Fei H-W, Halpern EF, et al. Myocardial strain is associated with adverse clinical cardiac events in patients treated with anthracyclines. J Am Soc Echocardiogr. 2016;29(6):522–7.e3. https://doi.org/10.1016/j.echo.2016.02.018 This study evaluated the usefulness of LV-GLS to stratify patients at high risk of cardiotoxicity after chemotherapy.CrossRefPubMed

Florescu M, Magda LS, Enescu OA, Jinga D, Vinereanu D. Early detection of epirubicin-induced cardiotoxicity in patients with breast cancer. J Am Soc Echocardiogr. 2014;27(1):83–92. https://doi.org/10.1016/j.echo.2013.10.008.CrossRefPubMed

10.

Sawaya H, Sebag Igal A, Plana Juan C, Januzzi James L, Ky B, Tan Timothy C, et al. Assessment of echocardiography and biomarkers for the extended prediction of cardiotoxicity in patients treated with anthracyclines, taxanes, and trastuzumab. Circ Cardiovasc Imaging. 2012;5(5):596–603. https://doi.org/10.1161/circimaging.112.973321.CrossRefPubMedPubMedCentral

11.

Ho E, Brown A, Barrett P, Morgan RB, King G, Kennedy MJ, et al. Subclinical anthracycline- and trastuzumab-induced cardiotoxicity in the long-term follow-up of asymptomatic breast cancer survivors: a speckle tracking echocardiographic study. Heart. 2010;96(9):701–7. https://doi.org/10.1136/hrt.2009.173997.CrossRefPubMed

12.

Rhea IB, Uppuluri S, Sawada S, Schneider BP, Feigenbaum H. Incremental prognostic value of echocardiographic strain and its association with mortality in cancer patients. J Am Soc Echocardiogr. 2015;28(6):667–73. https://doi.org/10.1016/j.echo.2015.02.006.CrossRefPubMed

13.

Handa N, McGregor CGA, Danielson GK, Daly RC, Dearani JA, Mullany CJ, et al. Valvular heart operation in patients with previous mediastinal radiation therapy. Ann Thorac Surg. 2001;71(6):1880–4. https://doi.org/10.1016/S0003-4975(01)02588-7.CrossRefPubMed

14.

Chirakarnjanakorn S, Popović ZB, Wu W, Masri A, Smedira NG, Lytle BW, et al. Impact of long-axis function on cardiac surgical outcomes in patients with radiation-associated heart disease. J Thorac Cardiovasc Surg. 2015;149(6):1643–51.e2. https://doi.org/10.1016/j.jtcvs.2015.01.045.CrossRefPubMed

15.

Sperry BW, Vranian MN, Tower-Rader A, Hachamovitch R, Hanna M, Brunken R, et al. Regional variation in technetium pyrophosphate uptake in transthyretin cardiac amyloidosis and impact on mortality. JACC Cardiovasc Imaging. 2018;11(2, Part 1):234–42. https://doi.org/10.1016/j.jcmg.2017.06.020.CrossRefPubMed

16.

Koyama J, Ray-Sequin Patricia A, Falk RH. Longitudinal myocardial function assessed by tissue velocity, strain, and strain rate tissue Doppler echocardiography in patients with AL (primary) cardiac amyloidosis. Circulation. 2003;107(19):2446–52. https://doi.org/10.1161/01.cir.0000068313.67758.4f.CrossRefPubMed

17.

•• Phelan D, Collier P, Thavendiranathan P, Popović ZB, Hanna M, Plana JC, et al. Relative apical sparing of longitudinal strain using two-dimensional speckle-tracking echocardiography is both sensitive and specific for the diagnosis of cardiac amyloidosis. Heart. 2012;98(19):1442. https://doi.org/10.1136/heartjnl-2012-302353 This study described regional patterns in longitudinal strain cardiac amyloidosis and differentiate it from other causes of increased left ventricular wall thickness.CrossRefPubMed

18.

Dungu JN, Anderson LJ, Whelan CJ, Hawkins PN. Cardiac transthyretin amyloidosis. Heart. 2012;98(21):1546–54. https://doi.org/10.1136/heartjnl-2012-301924.CrossRefPubMed

19.

Maurer MS, Schwartz JH, Gundapaneni B, Elliott PM, Merlini G, Waddington-Cruz M, et al. Tafamidis treatment for patients with transthyretin amyloid cardiomyopathy. N Engl J Med. 2018;379(11):1007–16. https://doi.org/10.1056/NEJMoa1805689.CrossRefPubMed

20.

Senapati A, Sperry BW, Grodin JL, Kusunose K, Thavendiranathan P, Jaber W, et al. Prognostic implication of relative regional strain ratio in cardiac amyloidosis. Heart. 2016;102(10):748–54. https://doi.org/10.1136/heartjnl-2015-308657.CrossRefPubMed

21.

Buss SJ, Emami M, Mereles D, Korosoglou G, Kristen AV, Voss A, et al. Longitudinal left ventricular function for prediction of survival in systemic light-chain amyloidosis: incremental value compared with clinical and biochemical markers. J Am Coll Cardiol. 2012;60(12):1067–76. https://doi.org/10.1016/j.jacc.2012.04.043.CrossRefPubMed

22.

• Tower-Rader A, Mohananey D, To A, Lever HM, Popovic ZB, Desai MY. Prognostic value of global longitudinal strain in hypertrophic cardiomyopathy: a systematic review of existing literature. JACC Cardiovasc Imaging. 2018. https://doi.org/10.1016/j.jcmg.2018.07.016 This is a systematic review with the most complete analysis on the value prognosis of LV-GLS in patients with HCM in recent years.PubMed

23.

Almaas VM, Haugaa KH, Strøm EH, Scott H, Smith H-J, Dahl CP, et al. Noninvasive assessment of myocardial fibrosis in patients with obstructive hypertrophic cardiomyopathy. Heart. 2014;100(8):631–8. https://doi.org/10.1136/heartjnl-2013-304923.CrossRefPubMed

24.

Tower-Rader A, Betancor J, Popovic ZB, Sato K, Thamilarasan M, Smedira NG, et al. Incremental prognostic utility of left ventricular global longitudinal strain in hypertrophic obstructive cardiomyopathy patients and preserved left ventricular ejection fraction. J Am Heart Assoc. 2017;6(10):e006514. https://doi.org/10.1161/jaha.117.006514.CrossRefPubMedPubMedCentral

25.

Nishimura RA, Otto CM, Bonow RO, Carabello BA, Erwin JP, Fleisher LA, et al. 2017 AHA/ACC focused update of the 2014 AHA/ACC guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association task force on clinical practice guidelines. J Am Coll Cardiol. 2017;70(2):252–89. https://doi.org/10.1016/j.jacc.2017.03.011.CrossRefPubMed

26.

Delgado V, Tops LF, van Bommel RJ, van der Kley F, Marsan NA, Klautz RJ, et al. Strain analysis in patients with severe aortic stenosis and preserved left ventricular ejection fraction undergoing surgical valve replacement. Eur Heart J. 2009;30(24):3037–47. https://doi.org/10.1093/eurheartj/ehp351.CrossRefPubMed

27.

Carasso S, Cohen O, Mutlak D, Adler Z, Lessick J, Aronson D, et al. Relation of myocardial mechanics in severe aortic stenosis to left ventricular ejection fraction and response to aortic valve replacement. Am J Cardiol. 2011;107(7):1052–7. https://doi.org/10.1016/j.amjcard.2010.11.032.CrossRefPubMed

28.

Kusunose K, Goodman A, Parikh R, Barr T, Agarwal S, Popovic Zoran B, et al. Incremental prognostic value of left ventricular global longitudinal strain in patients with aortic stenosis and preserved ejection fraction. Circul Cardiovasc Imaging. 2014;7(6):938–45. https://doi.org/10.1161/circimaging.114.002041.CrossRef

29.

Huded CP, Masri A, Kusunose K, Goodman AL, Grimm RA, Gillinov AM, et al. Outcomes in asymptomatic severe aortic stenosis with preserved ejection fraction undergoing rest and treadmill stress echocardiography. J Am Heart Assoc. 2018;7(8):e007880. https://doi.org/10.1161/jaha.117.007880.CrossRefPubMedPubMedCentral

30.

Magne J, Cosyns B, Popescu BA, Carstensen HG, Dahl J, Desai MY, et al. Distribution and prognostic significance of left ventricular global longitudinal strain in asymptomatic significant aortic stenosis: an individual participant data meta-analysis. JACC Cardiovasc Imaging. 2019;12(1):84–92. https://doi.org/10.1016/j.jcmg.2018.11.005.CrossRefPubMed

31.

Huded CP, Kusunose K, Shahid F, Goodman AL, Alashi A, Grimm RA, et al. Novel echocardiographic parameters in patients with aortic stenosis and preserved left ventricular systolic function undergoing surgical aortic valve replacement. Am J Cardiol. 2018;122(2):284–93. https://doi.org/10.1016/j.amjcard.2018.03.359.CrossRefPubMed

32.

Kafa R, Kusunose K, Goodman AL, Svensson LG, Sabik JF, Griffin BP, et al. Association of abnormal postoperative left ventricular global longitudinal strain with outcomes in severe aortic stenosis following aortic valve replacement LV global longitudinal strain values after aortic value replacement letters. JAMA Cardiol. 2016;1(4):494–6. https://doi.org/10.1001/jamacardio.2016.1132.CrossRefPubMed

33.

Dujardin Karl S, Enriquez-Sarano M, Schaff Hartzell V, Bailey Kent R, Seward James B, Tajik AJ. Mortality and morbidity of aortic regurgitation in clinical practice. Circulation. 1999;99(14):1851–7. https://doi.org/10.1161/01.cir.99.14.1851.CrossRef

34.

Alashi A, Mentias A, Abdallah A, Feng K, Gillinov AM, Rodriguez LL, et al. Incremental prognostic utility of left ventricular global longitudinal strain in asymptomatic patients with significant chronic aortic regurgitation and preserved left ventricular ejection fraction. JACC Cardiovasc Imaging. 2018;11(5):673–82. https://doi.org/10.1016/j.jcmg.2017.02.016.CrossRefPubMed

35.

Alashi A, Khullar T, Mentias A, Gillinov AM, Roselli EE, Svensson LG, et al. Long-term outcomes after aortic valve surgery in patients with asymptomatic chronic aortic regurgitation and preserved LVEF: impact of baseline and follow-up global longitudinal strain. JACC Cardiovasc Imaging. 2019. https://doi.org/10.1016/j.jcmg.2018.12.021.

36.

Mentias A, Naji P, Gillinov AM, Rodriguez LL, Reed G, Mihaljevic T, et al. Strain echocardiography and functional capacity in asymptomatic primary mitral regurgitation with preserved ejection fraction. J Am Coll Cardiol. 2016;68(18):1974–86. https://doi.org/10.1016/j.jacc.2016.08.030.CrossRefPubMed

37.

Mentias A, Alashi A, Naji P, Gillinov AM, Rodriguez LL, Mihaljevic T, et al. Exercise capacity in asymptomatic patients with significant primary mitral regurgitation: independent effect of global longitudinal left ventricular strain. Cardiovasc Diagn Ther. 2018;8(4):460–8.CrossRef

38.

Alashi A, Mentias A, Patel K, Gillinov AM, Sabik Joseph F, Popović Zoran B, et al. Synergistic utility of brain natriuretic peptide and left ventricular global longitudinal strain in asymptomatic patients with significant primary mitral regurgitation and preserved systolic function undergoing mitral valve surgery. Circ Cardiovasc Imaging. 2016;9(7):e004451. https://doi.org/10.1161/circimaging.115.004451.CrossRefPubMed

39.

Ersbøll M, Valeur N, Mogensen UM, Andersen MJ, Møller JE, Velazquez EJ, et al. Prediction of all-cause mortality and heart failure admissions from global left ventricular longitudinal strain in patients with acute myocardial infarction and preserved left ventricular ejection fraction. J Am Coll Cardiol. 2013;61(23):2365–73. https://doi.org/10.1016/j.jacc.2013.02.061.CrossRefPubMed

40.

Antończyk K, Niklewski T, Antończyk R, Zakliczyński M, Zembala M, Kukulski T. Evaluation of the graft mechanical function using speckle-tracking echocardiography during the first year after orthotropic heart transplantation. Ann Transplant. 2018;23:554–60. https://doi.org/10.12659/aot.909359.CrossRefPubMedPubMedCentral

41.

Eleid MF, Caracciolo G, Cho EJ, Scott RL, Steidley DE, Wilansky S, et al. Natural history of left ventricular mechanics in transplanted hearts: relationships with clinical variables and genetic expression profiles of allograft rejection. JACC Cardiovasc Imaging. 2010;3(10):989–1000. https://doi.org/10.1016/j.jcmg.2010.07.009.CrossRefPubMed

42.

Sade LE, Hazirolan T, Kozan H, Ozdemir H, Hayran M, Eroglu S, et al. T1 mapping by cardiac magnetic resonance and multidimensional speckle-tracking strain by echocardiography for the detection of acute cellular rejection in cardiac allograft recipients. JACC Cardiovasc Imaging. 2018;12:1601–14. https://doi.org/10.1016/j.jcmg.2018.02.022.CrossRefPubMed

43.

Barakat AF, Sperry BW, Starling RC, Mentias A, Popovic ZB, Griffin BP, et al. Prognostic utility of right ventricular free wall strain in low risk patients after orthotopic heart transplantation. Am J Cardiol. 2017;119(11):1890–6. https://doi.org/10.1016/j.amjcard.2017.03.003.CrossRefPubMed

44.

Mahmoud A, Bansal M, Sengupta PP. New cardiac imaging algorithms to diagnose constrictive pericarditis versus restrictive cardiomyopathy. Curr Cardiol Rep. 2017;19(5):43. https://doi.org/10.1007/s11886-017-0851-0.CrossRefPubMed

45.

Farsalinos KE, Daraban AM, Ünlü S, Thomas JD, Badano LP, Voigt J-U. Head-to-head comparison of global longitudinal strain measurements among nine different vendors: the EACVI/ASE inter-vendor comparison study. J Am Soc Echocardiogr. 2015;28(10):1171–81.e2. https://doi.org/10.1016/j.echo.2015.06.011.CrossRefPubMed

46.

Lang RM, Badano LP, Mor-Avi V, Afilalo J, Armstrong A, Ernande L, et al. Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. J Am Soc Echocardiogr. 2015;28(1):1–39.e14. https://doi.org/10.1016/j.echo.2014.10.003.CrossRefPubMed

47.

Voigt J-U, Pedrizzetti G, Lysyansky P, Marwick TH, Houle H, Baumann R, et al. Definitions for a common standard for 2D speckle tracking echocardiography: consensus document of the EACVI/ASE/industry task force to standardize deformation imaging. J Am Soc Echocardiogr. 2015;28(2):183–93. https://doi.org/10.1016/j.echo.2014.11.003.CrossRefPubMed

48.

Zghal F, Bougteb H, Réant P, Lafitte S, Roudaut R. Assessing global and regional left ventricular myocardial function in elderly patients using the bidimensional strain method. Echocardiography. 2011;28(9):978–82. https://doi.org/10.1111/j.1540-8175.2011.01476.x.CrossRefPubMed

49.

Takigiku K, Takeuchi M, Izumi C, Yuda S, Sakata K, Ohte N, et al. Normal range of left ventricular 2-dimensional strain: Japanese ultrasound speckle tracking of the left ventricle (JUSTICE) study. Circ J. 2012;76(11):2623–32. https://doi.org/10.1253/circj.CJ-12-0264.CrossRefPubMed

50.

Cifra B, Mertens L, Mirkhani M, Slorach C, Hui W, Manlhiot C, et al. Systolic and diastolic myocardial response to exercise in a healthy pediatric cohort. J Am Soc Echocardiogr. 2016;29(7):648–54. https://doi.org/10.1016/j.echo.2016.02.015.CrossRefPubMed

Title: Clinical Applications of Echo Strain Imaging: a Current Appraisal
Authors: Agostina M. Fava, MD
Dane Meredith, MD
Milind Y. Desai, MD
Publication date: 01-10-2019
Publisher: Springer US
Keywords: Aortic Valve Replacement
Cardiomyopathy
Aortic Valve Replacement
Aortic Valve Replacement
Published in: Current Treatment Options in Cardiovascular Medicine / Issue 10/2019
Print ISSN: 1092-8464
Electronic ISSN: 1534-3189
DOI: https://doi.org/10.1007/s11936-019-0761-0

ACC 2024 Congress Coverage

Heart Failure Video

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Clinical Applications of Echo Strain Imaging: a Current Appraisal

Abstract

Purpose of review

Recent findings

Summary

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Abstract

Purpose of review

Recent findings

Summary

Please log in to get access to this content

Other articles of this Issue 10/2019

Pulmonary Hypertension in Patients Eligible for Transcatheter Mitral Valve Repair: Prognostic Impact and Clinical Implications

Long-Term Prognostic Value of Stress Perfusion Cardiovascular Magnetic Resonance Imaging

The Impact of Pharmacist-Based Services Across the Spectrum of Outpatient Heart Failure Therapy

Paclitaxel-Based Devices for the Treatment of PAD: Balancing Clinical Efficacy with Possible Risk

Leadless Pacemakers: Recent and Future Developments

Clinical Applications of MRA 4D-Flow

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page